Birmingham-based XpertDox raises $1 million in funding


XpertDox, a Birmingham-based startup has closed a $1 million seed funding round.

Led by a group of private investors based in Birmingham, Ala. with coordination from the Birmingham Business Alliance, the company will use the money to advance its technology platform and add talent to its team.

XpertDoxXpertDox, which is located in Innovation Depot, leverages big data to improve patient access to health care and accelerate patient recruitment into clinical trials. Enabled by a proprietary algorithm, XpertDox has mapped more than 6,000 diseases, 4,500 hospitals, 18,000 clinical trials and all one million doctors in the United States, all to help patients find the best care for their disease.

“The closing of this financing represents a significant milestone for XpertDox,” said Dr. Sameer Ather, president and CEO of XpertDox and a cardiologist, researcher and professor at the University of Alabama at Birmingham. “This funding will allow us to continue to invest in the business, enhancing our capabilities to assist patients in finding the best doctor, hospital or clinical trial for their condition.”

“Funding is essential for high-growth startup companies like XpertDox to grow here in Birmingham,” added Devon Laney, president and CEO of tech incubator and accelerator Innovation Depot. “Locally raised funds for a startup are a sign that our ecosystem is getting stronger and that investors in our own backyard are recognizing the potential of backing our entrepreneurs.”

Ather has worked extensively with, among others, the Birmingham Business Alliance to advance XpertDox’s corporate development goals.

“We are grateful for the support we have received from the Birmingham business community and are dedicated to expanding our operations here,” Ather said.

Jon Nugent, Vice President of Innovation and Technology at the Birmingham Business Alliance, applauded XpertDox’s recent success.

“We are proud to have XpertDox in Birmingham and look forward to continuing to work with Dr. Ather and his team,” Nugent said.